Structure |
Chemical Name |
CAS |
MF |
![Hexanoic acid, 3-(hydroxymethyl)-, methyl ester, (3R)-](/CAS/20210111/GIF/2408196-94-9.gif) |
Hexanoic acid, 3-(hydroxymethyl)-, methyl ester, (3R)- |
2408196-94-9 |
C8H16O3 |
![Irinotecan Impurity L](/) |
Irinotecan Impurity L |
|
|
![Irinotecan Impurity H](/) |
Irinotecan Impurity H |
|
|
![Loratadine EP Impurity L](/) |
Loratadine EP Impurity L |
|
|
![LCZ696(valsartan + sacubitril) impurity 27](/) |
LCZ696(valsartan + sacubitril) impurity 27 |
|
|
![Caspofungin Impurity EJT2](/) |
Caspofungin Impurity EJT2 |
|
|
![Prasugrel Acetyl IMpurity](/CAS/20180906/GIF/1443034-67-0.gif) |
Prasugrel Acetyl IMpurity |
1443034-67-0 |
C18H18FNO3S |
![Piperacillin Impurity R](/) |
Piperacillin Impurity R |
|
|
![Propofol IMpurity G](/) |
Propofol IMpurity G |
|
|
![Lasmiditan Impurity 6](/) |
Lasmiditan Impurity 6 |
|
|
![SalMeterol IMpurity A](/CAS/20150408/GIF/CB42675644.gif) |
SalMeterol IMpurity A |
|
C25H37NO4 |
![1-methylpyrrolidin-3-yl 2-(4-chlorophenyl)-2-cyclopentyl- 2-hydroxyacetate hydrochloride](/) |
1-methylpyrrolidin-3-yl 2-(4-chlorophenyl)-2-cyclopentyl- 2-hydroxyacetate hydrochloride |
|
|
![Lasmiditan Impurity 8](/) |
Lasmiditan Impurity 8 |
|
|
![3-([(TERT-ブチルトキシ)カルボニル]アミノ)-4-(2,4-ジフルオロフェニル)ブタン酸](/CAS/20150408/GIF/851307-12-5.gif) |
3-([(TERT-ブチルトキシ)カルボニル]アミノ)-4-(2,4-ジフルオロフェニル)ブタン酸 |
851307-12-5 |
C15H19F2NO4 |
![N-Boc-シタグリプチン](/CAS/20200611/GIF/486460-23-5.gif) |
N-Boc-シタグリプチン |
486460-23-5 |
C21H23F6N5O3 |
![Ethacridine Impurity 10](/CAS/20211123/GIF/20304-71-6.gif) |
Ethacridine Impurity 10 |
20304-71-6 |
C21H16N2O4 |
![SulbactaM IMpurity D](/) |
SulbactaM IMpurity D |
|
|
![(S)-N-(1-Azabicyclo[2.2.2]oct-3-yl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamide](/CAS/GIF/135729-78-1.gif) |
(S)-N-(1-Azabicyclo[2.2.2]oct-3-yl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamide |
135729-78-1 |
C18H24N2O |
![2-(2-(4-chlorobenzoyl)phenoxy)-2-methylpropanoic acid](/) |
2-(2-(4-chlorobenzoyl)phenoxy)-2-methylpropanoic acid |
|
|
![Olodaterol Impurity 31](/) |
Olodaterol Impurity 31 |
|
|
![(S)-N-[(2S,4S,5S)-5-アミノ-4-ヒドロキシ-1,6-ジフェニルヘキサン-2-イル]-3-メチル-2-(2-オキソテトラヒドロピリミジン-1(2H)-イル)ブタンアミド](/CAS2/GIF/192726-05-9.gif) |
(S)-N-[(2S,4S,5S)-5-アミノ-4-ヒドロキシ-1,6-ジフェニルヘキサン-2-イル]-3-メチル-2-(2-オキソテトラヒドロピリミジン-1(2H)-イル)ブタンアミド |
192726-05-9 |
C27H38N4O3 |
![2-Hydrazinoadenosine](/CAS/GIF/15763-11-8.gif) |
2-Hydrazinoadenosine |
15763-11-8 |
C10H15N7O4 |
![N-Desmethyl Clarithromycin](/CAS/GIF/101666-68-6.gif) |
N-Desmethyl Clarithromycin |
101666-68-6 |
C37H67NO13 |
![3α-(ヒドラジノカルボニル)-3-デス(メトキシカルボニル)-4-O-デスアセチルビンカロイコブラスチン](/CAS/GIF/55383-37-4.gif) |
3α-(ヒドラジノカルボニル)-3-デス(メトキシカルボニル)-4-O-デスアセチルビンカロイコブラスチン |
55383-37-4 |
C43H56N6O7 |
![4-hydroxypyrrolidin-2-one](/CAS/GIF/96820-00-7.gif) |
4-hydroxypyrrolidin-2-one |
96820-00-7 |
C4H7NO2 |
![glycopyrronium bromide](/CAS/GIF/475468-09-8.gif) |
glycopyrronium bromide |
475468-09-8 |
C19H28NO3.Br |
![4'-ヒドロキシ フルルビプロフェン](/CAS/GIF/52807-12-2.gif) |
4'-ヒドロキシ フルルビプロフェン |
52807-12-2 |
C15H13FO3 |
![D-biotin-d-sulfoxide](/CAS/GIF/10406-89-0.gif) |
D-biotin-d-sulfoxide |
10406-89-0 |
C10H16N2O4S |
![3,4-ジヒドロキシフェニルピルビン酸](/CAS/GIF/4228-66-4.gif) |
3,4-ジヒドロキシフェニルピルビン酸 |
4228-66-4 |
C9H8O5 |
![delta(3)-cefotiam](/CAS/20150408/GIF/142182-63-6.gif) |
delta(3)-cefotiam |
142182-63-6 |
C18H23N9O4S3 |
![alpha-(chloromethyl)-2-hydroxymethyl-5-nitroimidazole-1-ethanol](/CAS/GIF/62580-79-4.gif) |
alpha-(chloromethyl)-2-hydroxymethyl-5-nitroimidazole-1-ethanol |
62580-79-4 |
C7H10ClN3O4 |
![4-hydroxypenicillin V](/CAS/20180808/GIF/20880-67-5.gif) |
4-hydroxypenicillin V |
20880-67-5 |
C16H18N2O6S |
![ベナゼプリラト](/CAS/GIF/86541-78-8.gif) |
ベナゼプリラト |
86541-78-8 |
C22H24N2O5 |
![2-(4-ピペリジニル)ベンゾイミダゾール](/CAS/GIF/38385-95-4.gif) |
2-(4-ピペリジニル)ベンゾイミダゾール |
38385-95-4 |
C12H15N3 |
![4-CHLORO-3,5-DIMETHYL 2-CHLORMETHYL PYRIDINE.HCL](/CAS/GIF/142885-96-9.gif) |
4-CHLORO-3,5-DIMETHYL 2-CHLORMETHYL PYRIDINE.HCL |
142885-96-9 |
C8H9Cl2N |
![1,3,5(10),9(11)-エストラテトラエン-3,17β-ジオール](/CAS/GIF/791-69-5.gif) |
1,3,5(10),9(11)-エストラテトラエン-3,17β-ジオール |
791-69-5 |
C18H22O2 |
![Pramipexole EP Impurity E](/CAS/GIF/106006-84-2.gif) |
Pramipexole EP Impurity E |
106006-84-2 |
C10H15N3OS |
![4-フェニルモルホリン-3-オン](/CAS/GIF/29518-11-4.gif) |
4-フェニルモルホリン-3-オン |
29518-11-4 |
C10H11NO2 |
![H 128/80](/CAS/GIF/29122-74-5.gif) |
H 128/80 |
29122-74-5 |
C13H19NO3 |
![4’-Hydroxy Atomoxetine -D-Glucuronide](/CAS/GIF/540729-08-6.gif) |
4’-Hydroxy Atomoxetine -D-Glucuronide |
540729-08-6 |
C23H29NO8 |
![Decarboxy Ciprofloxacin](/CAS/GIF/105394-83-0.gif) |
Decarboxy Ciprofloxacin |
105394-83-0 |
C16H18FN3O |
![ゾルピデム6-カルボン酸](/CAS/GIF/109461-15-6.gif) |
ゾルピデム6-カルボン酸 |
109461-15-6 |
C19H19N3O3 |
![テルミサルタンTERT-ブチルエステル](/CAS/GIF/144702-26-1.gif) |
テルミサルタンTERT-ブチルエステル |
144702-26-1 |
C37H38N4O2 |
![Amido Ethyl Meloxicam (Meloxicam Impurity)](/CAS/GIF/881399-30-0.gif) |
Amido Ethyl Meloxicam (Meloxicam Impurity) |
881399-30-0 |
C16H17N3O4S2 |
![3-メトキシ-2,4,5-トリフルオロベンゾイルクロリド](/CAS/GIF/112811-66-2.gif) |
3-メトキシ-2,4,5-トリフルオロベンゾイルクロリド |
112811-66-2 |
C8H4ClF3O2 |
![2-メトキシベンズアルデヒドジメチルアセタール](/CAS/20180906/GIF/58378-33-9.gif) |
2-メトキシベンズアルデヒドジメチルアセタール |
58378-33-9 |
C10H14O3 |
![N-(2-ベンゾイル-4-クロロフェニル)ホルムアミド](/CAS/GIF/10352-28-0.gif) |
N-(2-ベンゾイル-4-クロロフェニル)ホルムアミド |
10352-28-0 |
C14H10ClNO2 |
![6α-[(4-ヒドロキシフェニルアセチル)アミノ]ペニシラン酸ナトリウム](/CAS/20211123/GIF/5985-13-7.gif) |
6α-[(4-ヒドロキシフェニルアセチル)アミノ]ペニシラン酸ナトリウム |
5985-13-7 |
C16H19N2NaO5S |
![Valsartan N2-Trityl IMpurity](/) |
Valsartan N2-Trityl IMpurity |
|
|
![Vardenafil IMpurity 3](/CAS/20200611/GIF/1255919-01-7.gif) |
Vardenafil IMpurity 3 |
1255919-01-7 |
C26H30N6O4S |
![Montelukast Cyclopropaneacetonitrile](/CAS/GIF/866923-62-8.gif) |
Montelukast Cyclopropaneacetonitrile |
866923-62-8 |
C35H35ClN2OS |
![(2S,3R,4S,5S,6R)-2-(4-クロロ-3-(4-エトキシベンジル)フェニル)-6-(ヒドロキシメチル)-2-メトキシテトラヒドロ-2H-ピラン-3,4,5-トリオール](/CAS/20150408/GIF/461432-24-6.gif) |
(2S,3R,4S,5S,6R)-2-(4-クロロ-3-(4-エトキシベンジル)フェニル)-6-(ヒドロキシメチル)-2-メトキシテトラヒドロ-2H-ピラン-3,4,5-トリオール |
461432-24-6 |
C22H27ClO7 |
![Ezetimibe Impurity](/CAS/20211123/GIF/1510820-22-0.gif) |
Ezetimibe Impurity |
1510820-22-0 |
C24H23F2NO2 |
![10,13-bissidechainpaclitaxel](/) |
10,13-bissidechainpaclitaxel |
|
|
![フェキソフェナジンメチルエステル](/StructureFile/ChemBookStructure9/GIF/CB1457294.gif) |
フェキソフェナジンメチルエステル |
154825-96-4 |
C33H41NO4 |
![Bendamustine Related Impurity 21](/) |
Bendamustine Related Impurity 21 |
|
|
![Bendamustine Related Impurity 8](/) |
Bendamustine Related Impurity 8 |
|
|
![Bortezomib Impurity 33](/) |
Bortezomib Impurity 33 |
|
|
![Moxifloxacin Impurity 31](/) |
Moxifloxacin Impurity 31 |
|
|
![Pitavastatin Impurity 7](/) |
Pitavastatin Impurity 7 |
|
|
![Prednisolone Impurity A](/CAS/20200119/GIF/77017-17-5.gif) |
Prednisolone Impurity A |
77017-17-5 |
C21H26O5 |
![Rivaroxaban Impurity 61](/CAS/20200515/GIF/1643354-27-1.gif) |
Rivaroxaban Impurity 61 |
1643354-27-1 |
C32H30N4O8 |
![Rivaroxaban Impurity 74](/) |
Rivaroxaban Impurity 74 |
|
|
![Sitafloxacin Impurity 6](/) |
Sitafloxacin Impurity 6 |
|
|
![Ticagrelor Related Compound 75](/) |
Ticagrelor Related Compound 75 |
|
|
![Ticagrelor Related Compound 93](/CAS/20210111/GIF/2207528-55-8.gif) |
Ticagrelor Related Compound 93 |
2207528-55-8 |
C23H28F2N6O4S |
![Vonoprazan Impurity 24](/CAS/20200515/GIF/1807642-41-6.gif) |
Vonoprazan Impurity 24 |
1807642-41-6 |
C16H14FN3O2S |
![Vonoprazan Impurity 35](/) |
Vonoprazan Impurity 35 |
|
|
![Blonanserin Impurity L](/) |
Blonanserin Impurity L |
|
|
![Cefazolin USP Impurity E](/) |
Cefazolin USP Impurity E |
|
|
![Exemestane Impurity 5](/) |
Exemestane Impurity 5 |
|
|
![Medetomidine Impurity 28](/CAS/20200515/GIF/2240179-64-8.gif) |
Medetomidine Impurity 28 |
2240179-64-8 |
C23H28N2 |
![Peramivir Impurity 4](/CAS/20200515/GIF/229615-12-7.gif) |
Peramivir Impurity 4 |
229615-12-7 |
C15H28N4O4 |
![Peramivir Impurity 9](/) |
Peramivir Impurity 9 |
|
|
![PidotimodImpurity T](/) |
PidotimodImpurity T |
|
|
![(Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate](/CAS/20200331/GIF/2093243-16-2.gif) |
(Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
2093243-16-2 |
C17H13NO4 |
![Lenvatinib Impurity 10](/) |
Lenvatinib Impurity 10 |
|
|
![Nifuratel Impurity 10](/) |
Nifuratel Impurity 10 |
|
|
![Ozagrel Impurity 16](/CAS/20200611/GIF/143945-86-2.gif) |
Ozagrel Impurity 16 |
143945-86-2 |
C13H12N2O2 |
![Tofacitinib Impurity 68](/) |
Tofacitinib Impurity 68 |
|
|
![2-(4R,6S)(6-Formyl-2,2-dimethyl-[1,3]dioxan-4-yl)-acetic acid](/CAS/20200119/GIF/123185-91-1.gif) |
2-(4R,6S)(6-Formyl-2,2-dimethyl-[1,3]dioxan-4-yl)-acetic acid |
123185-91-1 |
C9H14O5 |
![5-(3-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3- carbaldehyde](/CAS/20200119/GIF/CB14661208.gif) |
5-(3-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3- carbaldehyde |
|
C16H11FN2O3S |
![Dapoxetine impurity](/CAS/20200515/GIF/126113-24-4.gif) |
Dapoxetine impurity |
126113-24-4 |
C19H16O2 |
![Loratadine Impurity 17](/CAS/20200119/GIF/133330-72-0.gif) |
Loratadine Impurity 17 |
133330-72-0 |
C14H12ClNO |
![Istradefylline Impurity A](/) |
Istradefylline Impurity A |
|
|
![(3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine dihydrochloride](/CAS/20150408/GIF/CB42682570.gif) |
(3R,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine dihydrochloride |
|
C14H24Cl2N2 |
![2-(((3-Methyl-4-nitropyridin-2-yl)Methyl)sulfinyl)-1H- benzo[d]iMidazole](/CAS/20150408/GIF/142384-07-4.gif) |
2-(((3-Methyl-4-nitropyridin-2-yl)Methyl)sulfinyl)-1H- benzo[d]iMidazole |
142384-07-4 |
C14H12N4O3S |
![Valsartan Desvaleryl Impurity](/CAS/20200611/GIF/676129-92-3.gif) |
Valsartan Desvaleryl Impurity |
676129-92-3 |
C19H21N5O2 |
![Istradefylline iMpurity](/) |
Istradefylline iMpurity |
|
|
![(E)-オロパタジン塩酸塩](/CAS/GIF/949141-22-4.gif) |
(E)-オロパタジン塩酸塩 |
949141-22-4 |
C21H24ClNO3 |
![(3R,4R,5R)-3-(1-エチルプロポキシ)-4-ヒドロキシ-5-[(メチルスルホニル)オキシ]-1-シクロヘキセン-1-カルボン酸エチルエステル](/CAS/GIF/204254-92-2.gif) |
(3R,4R,5R)-3-(1-エチルプロポキシ)-4-ヒドロキシ-5-[(メチルスルホニル)オキシ]-1-シクロヘキセン-1-カルボン酸エチルエステル |
204254-92-2 |
C15H26O7S |
![8-Hydroxy Pitavastatin](/CAS/GIF/224320-09-6.gif) |
8-Hydroxy Pitavastatin |
224320-09-6 |
C25H24FNO5 |
![過酢酸アロイン](/CAS/GIF/64951-96-8.gif) |
過酢酸アロイン |
64951-96-8 |
C37H38O17 |
![L-Alanine, N-[(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-, 1-Methylethyl ester](/CAS/20150408/GIF/1256490-52-4.gif) |
L-Alanine, N-[(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-, 1-Methylethyl ester |
1256490-52-4 |
C18H17F5NO5P |
![Cefditoren iMpurity 2, Cefditoren open ring](/) |
Cefditoren iMpurity 2, Cefditoren open ring |
|
|
![Ceftriaxone IMpurity C](/) |
Ceftriaxone IMpurity C |
|
|
![Etoricoxib iMpurity 2](/) |
Etoricoxib iMpurity 2 |
|
|
![Lorcaserin iMpurity D](/CAS/20180808/GIF/1030624-36-2.gif) |
Lorcaserin iMpurity D |
1030624-36-2 |
C11H14ClNO2 |
![Ticagrelor IMpurity L (Mixture of DiastereoMers)](/) |
Ticagrelor IMpurity L (Mixture of DiastereoMers) |
|
|
![α-Hydroxy-α-3-thienyl-2-thiopheneacetic Acid 9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl Ester](/CAS/20180808/GIF/783273-13-2.gif) |
α-Hydroxy-α-3-thienyl-2-thiopheneacetic Acid 9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl Ester |
783273-13-2 |
C18H19NO4S2 |